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Nat'l Nav Med cen & Unifonred Services University of the Health Sciences, Bethesda, Maryland In vitro characterization of angiotensin roodiated l\CTH release -We recently dsronstrated that angiotensin II (AIl) directly roodiates in vitro l\CTH secretion in rat pituitary cells.To investigate the structure activity relationship of the AIl IlDlecule and intracellular events involved in AIl roodiated l\CTH release _ studied: l)the l\CTH stimulatory activity of the AIl fragnents AIl (2-8) , and 2)the effect of isd:>utyl-3-rnethylxanthine(IBMX)an adenyl cyclase inhibitor,prostaglandin E2{PGE2)and cyproheptadine on AIl roodiated l\CTH release.Anterior rat pituitaries~enzyma-tically dispersed in trypsi.n/]:W\ase solution and placed in norolayer cell cultures.After 3 days of incubation r the cells were washed and inclbated for 4 hrs in test roodia whid1 was later asayed for l\CTH by RIA.AII{lOnM)elicited a 150-180% increase of l\CTH secretion over oontrol cells.A declining l\CTH releasing activity was dsronstrated with ead1 oonsecutive C tenninal aminoacid deletion fran AILAII with IBMX(lllf.I)released rore l\CTH over its oontrol (IBMX alone)than the AC1'H released by AIl over its oontrol(p<O.Ol). PGE2 (lIlM) decreased AIl roodiated AC1'H release (pen. 01) .Cyproheptadine (lllg/ml) did not alter AIl roodiated l\CTH secretion. In sumary the relative potencies of AIl C tenninal deletion are AII>AII(2-8»AII (3-8»AII{4-8).IBMX potentiates,PGE2 inhibits,and cyproheptadine has no effect on AIl roodiated l\CTH release.Thus the C tenninal ami.-noacids of AIl are ilrp:lrtant to its l\CTH stiroulatory activity.lt is suggested that hiqher intracellular C'1\MP sensitized AIl roodiated l\CTH release and f>GE 2 may be a factor in this process. The Kallman's syndrom is usually evocated at adolescence in front of the association of delayed puberty and anosmia. We recently observed 3 infants with extreme micropenis and bilateral cryptorchidism, in Whom the diagnosis of Kallman's syndrom was suspected on 1) low plasma testosterone level «0.15 ng/ml) and fail of this one to increase either spontaneously during the first trimester of life or after hCG stimulation test (3 X 500 U) 2) low basal LH value «1.4 llV/ml) with insuffisant rise «3.9 llV/ml) after LHRH (0.1 mg/m 2) at 2 months of age. In addition a familial evocative history was present in the 3 cases. The mother of one infant was followed for a Kallman's syndrom. Anosmia with or without cryptorchidism was noted in the familial history of the 2 others. These data indicate that 1) because of evocative clinical and biological features the diagnosis of Kallman's syndrom may be made early in infancy 2) an autosomic dominant mode of inheritance of this syndrom is involved. We studied a 10 yr old boy with Cushing's syndrome due to an ACTH secreting islet cell carcinoma of the pancreas. He had rapid weight gain, abdominal distention, proximal weakness but no hirsuĩ sm or striae. Height was -1 SD, weight was +2 SD and BP 130/90. Serum cortisol was 50-95 ug/dl without diurnal variation. Urinary free cortisol was 840 Ug/24 hrs and not suppressed by dexamethasone. Plasma ACTH was strikingly elevated and secreted episodically at 900-1600 pg/ml with similarly elevated 6LPH. Plasma calcitonin, LOR and a-fetoprotein concentrations were elevated. Hypokalemic alkalosis was present with normal plasma aldosterone but elevated renin and DOC. Plasma insulin to glucose ratio was normal. CT scan showed areas of punctate calcification in tail of pancreas. A tumor in the tail of the pancreas with extensive tumor nodules over the serosa was found. Tumor and both hyperplastic adrenals were removed to ameliorate Cushing's syndrome. An islet cell carcinoma was diagnosed histologically. Immunohistochemistry localized ACTH and insulin throughout the tumor. Tumor contained large amounts of 6LPH by RIA. SDS gel electrophoresis of immunoprecipitated cell free translation products coded by tumor mRNA indicated that ACTH and 6LPH arose from a common precursor molecule of 35000 daltons. A second patient, a 10 yr old girl with the same type of ACTH secreting islet cell CA was studied in 1957.
W. BECKX, P. HEIDEMANNx and P. STUBBE, P. SCHWARZX 150 Department of Pediatrics, University of Gottingen, 0-3400 Gottingen, FRG Transient hypergonadotropic hypogonadism, SHBG deficiency and hyperprolactinemia in children with ALL during induction chemotherapy.
The hypothalamo-pituitary-gonadal axis was investigated in 4 pb ertal boys (P 4-5) and in Z prepubertal girls with acute lymphocytic leukemia (ALL). LH, FSH, PRL, the response to LHRH/TRH as well as testosterone (T), estradiol (EZ) and sex-hormone-binding globulin (SHBG) were measured in each patient before therapy, on day 10 and ZI during, and 7 and 30 days after induction therapy. T, EZ and SHBG decreased in all patients together with a reduction in testicular volumes in pubertal boys (from ZO-Z5 ml to lZ-15 ml).
T (ng/100 ml) (EZ pg/ml) (SHBG (nmol/l binding sides) before
Zld before Zld before Zld boys 154 t76 3Z t19 45 t16 lotI Z7±13 16=5 girls zot 8 5±0.1 zot 7 11±1 70±11 3Z±5 Transient hypergonadotropic hypogonadism occured (mean LH from 9 mIU/ml to 18 mIU/ml, mean FSH from 7 mIU/ml to 15 mIU/ml) within ZI days of treatment. Simultaneously, mean prolactin levels increased from 8 ng/ml to 17 ng/ml together with an increased response to TRH stimulation. We conclude that during induction therapy in children with ALL a transient hypergonadotropic hypogonadism occured induced by a decreased steroid synthesis at the gonadal level and/or by a decreased SHBG synthesis. 
